JOHN MENDLEIN - 29 Jul 2021 Form 3 Insider Report for Omega Therapeutics, Inc. (OMGAQ)

Role
Director
Signature
/s/ Barbara Chan as Attorney-in-fact for John Mendlein, Ph.D.
Issuer symbol
OMGAQ
Transactions as of
29 Jul 2021
Net transactions value
$0
Form type
3
Filing time
29 Jul 2021, 21:04:23 UTC
Previous filing
04 Jun 2021
Next filing
11 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding OMGA Stock Option (Right to Buy) 29 Jul 2021 Common Stock 221,360 $0.6000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest and become exercisable with respect to 25% of the underlying shares on January 14, 2021 and in equal quarterly installments thereafter such that the option will become fully vested and exercisable on January 14, 2024, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Remarks:

Exhibit 24 - Power of Attorney.